Intradermal DNA Vaccination Enhanced by Low-Current Electroporation Improves Antigen Expression and Induces Robust Cellular and Humoral Immune Responses

DNA represents an ideal vaccine platform for HIV and many infectious diseases because of its safety, stability, and ease of manufacture. However, the immunogenicity of DNA vaccines has traditionally been low compared with viral vectors, recombinant protein, and live attenuated vaccines. The immunoge...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Hutnick, Natalie A., Myles, Devin J.F., Ferraro, Bernadette, Lucke, Colleen, Lin, Feng, Yan, Jian, Broderick, Kate E., Khan, Amir S., Sardesai, Niranjian Y., Weiner, David B.
التنسيق: Artigo
اللغة:Inglês
منشور في: Mary Ann Liebert, Inc. 2012
الموضوعات:
Research Articles
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC3440022/
https://ncbi.nlm.nih.gov/pubmed/22650607
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/hum.2012.055
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة